IPR infringement in the United States: impacts on the input and output of R&D

The Journal of Technology Transfer - This paper examines the impact of intellectual property rights (IPR) infringement on the input (R&D spending) and output (patents) of the research...     

Industrial R&D Laboratories: Windows on Black Boxes?

This paper provides an overview of the survey-based literature on industrial Research and Development (R&D) laboratories, beginning with the work of Edwin Mansfield. Topics covered include R&D projects, new products, and new processes; the appropriability of intellectual property; the limits of the firm in R&D; and spillovers of knowledge from other firms and universities into the laboratories. I discuss the value of collecting information from industrial R&D managers, who participate in a wide range of R&D decisions and are the natural best source of information on these decisions. I also emphasize gaps in our knowledge concerning R&D from past studies, such as the private and social returns to R&D, the nature of firms' R&D portfolios, and other topics. The paper closes with a discussion of the benefits from building a national database on R&D laboratories that could be shared among researchers and that could take this area of research to a new and higher level of achievement.     

Assessing the relationship between R&D subsidy,R&D cooperation and absorptive capacity: an investigation on the manufacturing Spanish case

Private companies want to eliminate outgoing spillovers while policymakers seek to maximize them. With subsidized R&D cooperation agreements both agents partially achieve their objectives. For this reason, in Europe, policymakers grant subsidies for R&D activities with the condition of establishing R&D cooperation agreements. This study explores the relationship of complementarity between R&D subsidy, R&D cooperation and absorptive capacity in the context of its contribution to labor productivity of enterprises. The data used comes from the Technological Innovation Panel (PITEC), managed by the Spanish National Statistics Institute. We selected manufacturing companies in the period 2008–2013. We evaluate the existence of complementarity through the systems approach and the interaction approach. The econometric technique that we used to estimate the coefficients of our empirical model was maximum-likelihood random effects. As a consequence of the low absorptive capacity of Spanish manufacturing firms we find that R&D subsidies and R&D cooperation agreements are not complementary variables, i.e., receiving public subsidies as a result of establishing R&D cooperation agreements has a lower impact on productivity than the sum of the individual impacts of R&D cooperation and R&D subsidies. In consequence, this result calls into question the convenience of using subsidized R&D cooperation agreements as a tool for promoting innovation in EU countries as there are notable differences between the companies in these countries in terms of absorption capacity.     

The effect of competitive and non-competitive R&;D collaboration on firm innovation

A firm can improve its innovation either by its internal research and development (R&D) efforts or by forming external collaborative R&D alliances. While previous studies on R&D collaboration and knowledge diffusion mainly focus on various external sources of R&D collaboration, little effort has been made to investigate the joint impact of competitive and non-competitive R&D collaborations on firm innovation simultaneously. By examining the data of 165 Taiwanese firms in the information and communication technology industry, we find that: (1) non-competitive R&D collaborations with universities have a positive direct impact on firm’s innovation performance; and (2) both non-competitive and competitive R&D collaborations have a positively moderating effect on the relationship between a firm’s internal R&D efforts and firm innovation and the positive moderating effect is higher for non-competitive R&D collaborations than that of competitive R&D collaborations. These findings suggest that R&D collaborations, either non-competitive or competitive, exhibit the nature of a win–win situation. We also derive implications for firms’ selection of R&D alliance partners and government policies.     

The structure and dynamics of the global network of inter-firm R&D partnerships 1989–2002

Research and development (R&D) partnerships are formed to share the risks and benefits of R&D. At the macro level, they result in a globe-spanning network that can be a valuable source of international knowledge spillovers. This network is the subject of a considerable body of literature. Often-made claims are that R&D collaboration is an important activity in a competitive environment, but that the importance of international partnerships has declined over time. Furthermore, it is claimed that collaborations are disproportionally concentrated within the developed economies. However, this literature fails to account for variations in the sizes of underlying firm populations between countries and over time. We argue that these population sizes create an opportunity structure of available collaboration partners for firms, and that ignoring variations in this structure potentially leads to erroneous conclusions about the structure and dynamics of the R&D network. To address this problem, we study the structure and dynamics of the global R&D network on an international and cross-industry scale using longitudinal data for 1989?C2002. We integrate data on public firms and their R&D partnerships and confront earlier findings with our data and a set of methods, which enables us to correct for the structure and dynamics in the firm population. While our study confirms previous findings concerning the worldwide trend in collaborative activity, it also shows that results on individual countries need correction. In particular, the importance of R&D collaboration for US companies is overestimated, while their openness towards foreign partners is underestimated.     

Research collaboration in the European community: Lessons for the US

Research collaboration between government, universities, and industry, as well as among member nations, has been a prominent strategy in the European Community's science and technology policy through the 1980s and into the 1990s. In the perspective of the Single European Act and 1992 Plan, this paper outlines the lessons from European research collaboration for the United States. The structure of the European Community's cooperative R&D programs are reviewed and support for the development of advanced materials is highlighted. In the context of the benefits from the European Community's programs, five policy implications can be discerned for the US: establishment of forums for industry and government to dialogue about research priorities, institution of programs to promote strategic industrial R&D through cost-sharing, encouragement of small and medium-size firms to cooperate in R&D in high-technology sectors, monitoring of European research and development programs, and development of reciprocity policies for foreign-company membership in national collaborative R&D programs. Mary T. Tyszkiewicz is senior research associate in the Technology and Information Policy Program at Syracuse University. She has an MS in inorganic chemistry from Iowa State University and MSc. in Science, Technology, and Industrialization from the Science Policy Research Unit at University of Sussex in Brighton, England.     

R&D consortia: Impact on competitiveness?

This research examines the impact of research and development (R&D) consortia on the competitiveness of American companies. It also concludes that since passage of the 1984 National Collaborative Research Act, which allows companies to jointly perform research, only a few R&D consortia have been formed and they do not have much impact on companies through applications of new technology. It is suggested that R&D consortia may have more impact on firms that are catching-up technologically or for which the particular research is tangential to their core business. He holds a Ph.D. in public policy from the George Washington University (1988), and has worked for the National Science Foundation, the Congressional Office of Technology Assessment, and the National Academy of Sciences. His interests focus on technology, economic competitiveness, and government policy. He has recently published on these topics in Research Policy (August 1990), and Policy Studies Review (Spring 1991, forthcoming).     

论中国《反垄断法》实施中的相关市场界定

Defining relevant markets is the foundation of establishing main antimonopoly regimes and the key issue in enforcing antimonopoly law, which often reflects the leniency or strictness of enforcement. In the process of defining relevant product market, the main factors to be considered include physical function and use purpose of product, product price, consumers’ preference and substitutable possibility of product supply. In defining relevant geographic market, the main consideration involves transportation cost and product characteristics, product price, consumers’ preference and barriers to market access. On the occasion of forthcoming enforcement of the Antimonopoly Law of China, the enforcement authorities should draw up a specific rule of the definition of relevant markets. Wang Xianlin got his Ph.D from Law School of Renmin University of China (2001) and is a Fulbright visiting scholar at Law School of George Washington University (2007–2008). Prof. Wang is a director of Economic Law Institute and a doctoral tutor in Shanghai Jiao Tong University School of Law. He was once a member of the advisory committee of antimonopoly legislation of the Legal Affairs Office of the State Council of P.R.C. and is a standing director of the Economic Law Academy affiliated with China Law Society. His research focuses on competition law and intellectual property law. He has ten books published individually or cooperatively, including the monograph, such as the Intellectual Property and Antimonopoly Law—Studies on antimonopoly issues of abuse of intellectual property rights and WTO competition policy and Chinese antimonopoly legislation and abuse of intellectual property rights and its regulation. Moreover, he has released over 100 papers in academic journals. In recent years, his research is focused on China’s antimonopoly legislation and the abuse of IPRs of multinational companies in China.     

“We really don’t want to move,but...”: identity and strategy in the internationalisation of industrial R&;D

In Norway, as in many other high-cost OECD countries in a geographical and cultural periphery, policy-makers seem to have given up attempts at attracting large numbers of foreign R&D investments. Instead, a major focus of innovation policies is to help companies internationalise yet with an aim to maintain or even increase their level of R&D and other innovation activities nationally. Based on case studies of eight Norwegian companies and their motives for and experiences with internationalisation of R&D, this article questions this policy. From the perspective of the companies, many factors explain how, why and where they carry out their R&D activities.      

Measuring the Economic Returns from Successful NASA Life Sciences Technology Transfers

Since 1958 NASA has invested approximately $3.7 billion in life sciences R&D in the support of the successful human space flight program. There are numerous studies documenting the spin-off technologies that can be traced to NASA research and development activities. Most of these studies describe the technologies and their uses; however only a few measure the economic impact of the spin-offs and most of these are benefit/cost studies that tend to overstate benefits or underestimate costs. This study takes a different approach, measuring only economic impacts to the companies that developed successful spin-off products from NASA life sciences investments. A personal interview was conducted with each company and the benefits are conservatively estimated as the value-added by the NASA technology to the company's output and the amount of additional private R&D stimulated by the NASA R&D.This pilot study of fifteen companies, using a very conservative measurement technique, found a large return to companies that have successfully commercialized NASA life sciences spin-off products. Value-added benefits totaled over $3.7 billion in life sciences R&D in the support of the successful human space flight program. There are numerous studies documenting the spin-off technologies that can be traced to NASA research and development activities. Most of these studies describe the technologies and their uses; however only a few measure the economic impact of the spin-offs and most of these are benefit/cost studies that tend to overstate benefits or underestimate costs. This study takes a different approach, measuring only economic impacts to the companies that developed successful spin-off products from NASA life sciences investments. A personal interview was conducted with each company and the benefits are conservatively estimated as the value-added by the NASA technology to the company's output and the amount of additional private R&D stimulated by the NASA R&D.This pilot study of fifteen companies, using a very conservative measurement technique, found a large return to companies that have successfully commercialized NASA life sciences spin-off products. Value-added benefits totaled over 1.5 billion and a NASA R&D total investment in these 15 technologies of 64 million was found to stimulate an additional64 million was found to stimulate an additional 200 million in private R&D.     

University and inter-firm R&D collaborations: propensity and intensity of cooperation in Europe

This paper investigates the determinants of firms’ decision to cooperate in R&D with universities and the intensity of the cooperation effort, in relation to the engagement in inter-firm R&D collaborations. Using novel survey data for seven EU countries between 2007 and 2009, our analysis accounts for unobservable factors influencing R&D cooperation forms and addresses the main endogeneity issues. We find that internal knowledge, appropriability conditions and incoming spillovers explain a large variation of the probability and of the intensity of R&D collaborations of European firms with universities (and comparably with unaffiliated companies).     

中国限制外国企业对知识产权滥用的立法思考

中国加入世界贸易组织 ,外国企业和跨国公司利用专利许可 ,对中国企业产品和技术连续发起狙击 ,引发国民对知识产权滥用的关注。中国应从国际贸易规则的原则与方法出发提高对限制知识产权滥用的认识 ,建立制裁国外、国内市场知识产权滥用的系统完整的法律体系。尽管各国反击知识产权滥用的立法层次与力度不同 ,但中国已有能力根据不断变化的形势、特点及自身要求 ,制定具创新意义的限制知识产权滥用的法律 ,设立独立的权威的反垄断执法审查机关。     

Internationalisation of R&D and embeddedness: the case of Austria

Internationalisation of corporate R&D—driven mainly by multinational enterprises (MNEs)—has received increasing interest recently. As a small open economy, Austria faces special challenges with regard to this on-going process. The share of Austrian R&D financed from abroad is outstanding in international comparison. Indeed, a significant portion of R&D activities in Austria is defined by strategic decisions of international corporations, which are re-assessing their spatial division of labour continuously. In our paper, we analyse the characteristics of these foreign-owned corporations in Austria and demonstrate that they form the more ‘modern’ part of Austrian industry. At the same time, we show that these companies and R&D facilities are embedded in the Austrian national innovation system (NIS) to a large extent. This embeddedness is also explicitly and implicitly supported by the Austrian technology policy. We conclude that this high degree of embeddedness in the NIS may be crucial for the sustainability of foreign-owned R&D facilities.

Firm heterogeneity,absorptive capacity and technical linkages with external parties in Italy

While it is widely acknowledged that internal R&D is a fundamental source of the ability to absorb, select and use external knowledge, severe data limitations prevent from capturing differences across firms in this respect. Using a novel dataset supplied by the Italian Bureau of Statistics, we highlight that, when controlling for internal R&D efforts, not all firms are equally prone to gain access to external technology, and to the knowledge provided by universities in particular. We find that firms which do not only perform R&D activities but also belong to a group exhibit a higher propensity to access external knowledge by either contracting out R&D or cooperating with external parties, as compared to independent firms that are not organized into groups. This premium persists when controlling for different measures of internal R&D efforts. Furthermore, the differential in the propensity to access external knowledge is particularly high in the case of R&D performers belonging to foreign groups, i.e. Italian affiliates of foreign owned companies; and it is even higher in the case of the few Italian firms that have R&D activities abroad. The relative dis-advantage of independent firms, which represent the bulk of the Italian industry and include most small and medium sized enterprises, appears to be less of an obstacle in the case of linkages with universities, especially when R&D contracting out is considered.     

Location choices within global innovation networks: the case of Europe

Rapid growth in internationalization of corporate R&D has spurred considerable interest since the 1990s. Foreign R&D is still mainly driven by the expansion of international production, but technology sourcing has become an increasingly important driver of dispersion. Actually, differences across sectors and companies tend to obscure the mix of motivations behind the development of global innovation networks. This paper distinguishes the various drivers of the international dispersion of corporate R&D in order to elaborate a typology of foreign R&D units, including in emerging countries. This typology is used to discuss the emergence of differentiated global innovation networks and the location choices by type of R&D unit. It is applied to foreign R&D projects in Europe in high and low cost countries between 2002 and 2005. It is then used to discuss the weakening attractiveness of the European Union for R&D activities and the relevant policies that countries can design to attract different types of units.

Doing technology transfer in federal laboratories (Part 1)

According to data from the Congressional General Accounting Office and the Association of University Technology Managers, the federal laboratories seriously lag some universities in rates of technology transfer. This paper, based on interviews with technology-transfer professionals in federal laboratories and universities, discusses the phenomenon of technology transfer, highlighting subjects such as technology push and market pull, cooperative R&D, technology licensing, start-up companies, information-dissemination and technology-search programs, technology transfer and local development, models of technology-transfer programs, limits to federal technology transfer, and measurement of technology transfer. It concludes that the explanation for the difference in technology-transfer rates between federal laboratories and universities is due primarily to the way technology-transfer opportunities are marketed in the two sectors.     

Patent laws and innovation in China

This paper explores whether the patent laws and intellectual property rights (IPR) system in China have resulted in innovation during the reform period. Subject to criticism on account of imperfect enforcement, the patent law system has produced a stock of patents which has grown rapidly alongside economic growth. The success rate of patent applications is similar across the country despite the considerable regional disparities in income and in the level of innovation. This paper presents a simple model of patent production in China derived from the patent law system that also considers the relevant contextual factors that could influence innovation. The main innovation input of R&D personnel is found to be a significant determinant of patents. While per capita GDP increases the propensity to innovate across all regions, notable heterogeneity exists whereby the coastal, central and interior areas are associated with different factors that produce innovation and influence the innovation process. The paper concludes that China's imperfect IPR system is nevertheless generating innovation as the country develops and hinges on the key factor of researchers.     

R&;D productivity and the organization of cluster policy: an empirical evaluation of the Industrial Cluster Project in Japan

Industrial clusters have attracted increasing attention as important locations of innovation. Therefore, several countries have started promotion policies for industrial clusters. However, there are few empirical studies on cluster policies. This paper examines the effects of the “Industrial Cluster Project” (ICP) in Japan on the R&D productivity of participants, using a unique dataset of 229 small firms, and discusses the conditions necessary for the effective organization of cluster policies. Different from former policy approaches, the ICP aims at building collaborative networks between universities and industries and supports the autonomous development of existing regional industries without direct intervention in the clustering process. Thus far, the ICP is similar to indirect support systems adopted by successful European clusters. Our estimation results suggest that participation in the cluster project alone does not affect R&D productivity. Moreover, research collaboration with a partner in the same cluster region decreases R&D productivity both in terms of the quantity and quality of patents. Therefore, in order to improve the R&D efficiency of local firms, it is also important to construct wide-range collaborative networks within and beyond the clusters, although most clusters focus on the network at a narrowly defined local level. However, cluster participants apply for more patents than others without reducing patent quality when they collaborate with national universities in the same cluster region.     

Innovation-related data in bureau of economic analysis international economic surveys

This paper describes innovation-related data available from international economic surveys conducted by the U.S. Bureau of Economic Analysis. These data are collected in conjunction with the international transactions accounts of the United States and in surveys of the operations of multinational companies (MNCs). The paper focuses on five innovation-related series: receipts and payments of royalties and license fees; exports and imports of research, development, and testing services; sales of services by foreign affiliates classified in the research and development services industry; MNC R&D spending; and MNC R&D employment.

Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)

The paper briefly outlines the status of technology transfer related issues in drugs & pharma and biotechnology sectors in India. The paper also outlines the contemporary business strategies including R&D and technology transfer models. The study indicates that present technology transfer policies and mechanisms are weak and need to be restructured. The current fiscal incentives and tax concessions etc. available for R&D in industry seem to have outlived and are no longer attractive because of continuous lowering of tariff rates and tax rates in the context of WTO and liberalization of policies. Moreover, the issue of R&D support to industry is not covered in the WTO as in case of subsidies. Therefore, it is advisable for the government to revisit the existing promotional measures for R&D. FDI policies also need to be tailored to encourage Technology transfers and capability building. Recommendations are made for making Technology Transfer more effective for the growth and competitiveness of the industry. A technology transfer management model is suggested.